We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
(-64%)
Cap. Flow
-$1.51B
Cap. Flow
% of AUM
-46.09%
Top 10 Holdings %
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$99.8M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$86.3M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$48M |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$23M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$36.3M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$31.4M |
| 3 |
Apple
AAPL
|
+$30.2M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$29.6M |
| 5 |
Microsoft
MSFT
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.66% |
| 2 | Financials | 8.46% |
| 3 | Healthcare | 8.24% |
| 4 | Consumer Discretionary | 7.74% |
| 5 | Industrials | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFI
3501
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $33K | ﹤0.01% |
+15,419
| New | +$25.4K |
|
|
PHAS
3502
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $33K | ﹤0.01% |
9,886
-6,779
| -41% | -$24.3K |
|
|
NP
3503
DELISTED
Neenah, Inc. Common Stock
NP
| $33K | ﹤0.01% |
601
-12,843
| -96% | -$590K |
|
|
NFH
3504
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
| $33K | ﹤0.01% |
3,871
+1,153
| +42% | +$9.95K |
|
|
MRLN
3505
DELISTED
Marlin Business Services Corp
MRLN
| $33K | ﹤0.01% |
2,726
-6,246
| -70% | -$60.9K |
|
|
EBSB
3506
DELISTED
Meridian Bancorp, Inc.
EBSB
| $33K | ﹤0.01% |
2,236
-42,990
| -95% | -$572K |
|
|
ARC
3507
DELISTED
ARC Document Solutions, Inc.
ARC
| $33K | ﹤0.01% |
+22,365
| New | +$28.5K |
|
3508
American Outdoor Brands
AOUT
$161M
| $32K | ﹤0.01% |
1,878
-9,156
| -83% | -$138K |
|
|
BRY
3509
DELISTED
Berry Corp
BRY
| $32K | ﹤0.01% |
8,848
-59,229
| -87% | -$205K |
|
|
CSW
3510
CSW Industrials
CSW
$5.59B
| $32K | ﹤0.01% |
289
-13,206
| -98% | -$1.32M |
|
|
ETNB
3511
DELISTED
89bio
ETNB
| $32K | ﹤0.01% |
1,299
-2,456
| -65% | -$62.8K |
|
3512
Shift4
FOUR
$3.79B
| $32K | ﹤0.01% |
426
-10,200
| -96% | -$610K |
|
3513
HealthStream
HSTM
$849M
| $32K | ﹤0.01% |
1,429
-19,773
| -93% | -$397K |
|
3514
LCNB Corp
LCNB
$285M
| $32K | ﹤0.01% |
2,148
-9,436
| -81% | -$138K |
|
3515
MP Materials
MP
$9.91B
| $32K | ﹤0.01% |
+992
| New | +$19.2K |
|
3516
NETGEAR
NTGR
$647M
| $32K | ﹤0.01% |
789
-24,100
| -97% | -$820K |
|
3517
Intellia Therapeutics
NTLA
$1.66B
| $32K | ﹤0.01% |
580
-5,494
| -90% | -$200K |
|
|
IMDX
3518
Insight Molecular Diagnostics
IMDX
$121M
| $32K | ﹤0.01% |
671
-2,004
| -75% | -$73.5K |
|
3519
OneSpan
OSPN
$624M
| $32K | ﹤0.01% |
1,540
-33,506
| -96% | -$720K |
|
|
SJT
3520
San Juan Basin Royalty Trust
SJT
$129M
| $32K | ﹤0.01% |
+11,799
| New | +$36.6K |
|
3521
TOMI Environmental Solutions
TOMZ
$14.4M
| $32K | ﹤0.01% |
+2,308
| New | +$43.5K |
|
|
XOMA
3522
DELISTED
Xoma
XOMA
| $32K | ﹤0.01% |
724
-4,368
| -86% | -$132K |
|
3523
XPEL
XPEL
$1.39B
| $32K | ﹤0.01% |
633
-14,625
| -96% | -$529K |
|
|
IVAC
3524
DELISTED
Intevac Inc
IVAC
| $32K | ﹤0.01% |
4,470
-18,524
| -81% | -$111K |
|
|
PETQ
3525
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $32K | ﹤0.01% |
829
-8,191
| -91% | -$254K |
|
Similar funds
CA
ICP
AP
BWA
JSW
SP
GCM
ZP
Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review
As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.
- Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
- Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
- Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
- Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
- Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
- Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.